Prof. Esen Demir is a pediatric chest disease specialist with board certification in Pediatric Chest Diseases (2011). Currently affiliated with Acibadem Health Group since 2023, M.D. Demir combines clinical expertise and a patient-centered approach to diagnose and manage respiratory conditions in children. M.D. Demir is an active member of several professional organizations, including the Pediatric Chest Diseases Association, Turkish Thoracic Society, Turkish Pediatric Association, Pediatric Asthma and Allergy Academy Association, National Pediatric Association of Turkey, and the Pediatric Respiratory Diseases and Cystic Fibrosis Association. These memberships reflect a commitment to staying current with advances in pediatric respiratory care, asthma and allergy management, and cystic fibrosis treatment. Known for clear communication with families and a collaborative care style, M.D. Demir focuses on evidence-based treatments, preventive care, and improving long-term respiratory health for children.
Education
- 2011 Board of Medical Specialization Pediatric Chest Diseases
- 1995 Ege University Faculty of Medicine Pediatric Allergy
- 1984 Ege University Faculty of Medicine, Pediatrics
- 1978 Ege University Faculty of Medicine
Experience
- 2023 Acibadem Health Group
- 2021 – 2023 Private Practice
- 2000 – 2022 EÜTF Pediatrics Allergy BD Prof. Dr.
- 1996 – 2000 EÜTF Pediatrics Allergy BD Associate Professorship
- 1990 – 1996 EÜTF Pediatrics Allergy BD Specialization
- 1985 – 1990 Chief Assistant and Deputy Chief at İzmir Behçet Uz Children’s Hospital
Memberships
- Pediatric Chest Diseases Association
- Turkish Thoracic Society
- Turkish Pediatric Association
- Pediatric Asthma and Allergy Academy Association
- National Pediatric Association of Turkey
- Pediatric Respiratory Diseases and Cystic Fibrosis Association
Publications
- Successful treatment of post-pericardiotomy syndrome via C1 inhibitor replacement therapy in a hereditary angioedema patient with Marfan syndrome
Turk J Pediatr. 2023;65(2):338-343. doi: 10.24953/turkjped.2022.637 - Clinical characteristics of patients requiring lung transplantation referral in national cystic fibrosis registry data.
Turk J Pediatr. 2023;65(2):257-268. doi: 10.24953/turkjped.2021.4930 - Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?
Pediatr Pulmonol. 2023 Sep;58(9):2505-2512. doi: 10.1002/ppul.26535. Epub 2023 Jun 6.
